ACHV: Achieve Life Sciences, Inc. Stock

by  •  • Comments Off on ACHV: Achieve Life Sciences, Inc. Stock

SIC 2835 – In Vitro and In Vivo Diagnostic Substances

Valuation
Market Cap ($M) 87.06
Enterprise Value ($M) 62.54
Book Value ($M) 20.90
Book Value / Share 0.60
Price / Book 4.17
NCAV ($M) 18.73
NCAV / Share 0.54
Price / NCAV 4.65

Profitability (mra)
Return on Invested Capital (ROIC) -1.29
Return on Assets (ROA) -0.57
Return on Equity (ROE) -0.81

Liquidity (mrq)
Quick Ratio 5.46
Current Ratio 5.46

Balance Sheet (mrq) ($M)
Current Assets 36.47
Assets 38.63
Liabilities 17.73
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -39.07
Net Income -39.83
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -29.77
Cash from Investing -21.58
Cash from Financing 48.53

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-12 13G/A Vanguard Group Inc 5.65 0.00
10-31 13G/A Franklin Resources Inc 16.60 38.63
10-25 13G BlackRock, Inc. 6.00
05-20 13G/A Contrarian Alpha, LP 6.60 9.77
05-17 13G Propel Bio Management, LLC 6.81

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-11 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-02 38,091 131,329 29.00
2025-04-01 49,993 121,042 41.30
2025-03-31 22,721 69,022 32.92
2025-03-28 18,300 75,583 24.21

(click for more detail)

Similar Companies
ABEO – Abeona Therapeutics Inc. ABVC – ABVC BioPharma, Inc.
ACB – Aurora Cannabis Inc. ACXP – Acurx Pharmaceuticals, Inc.
ADIL – Adial Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io